MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Epigenetic clock acceleration is linked to earlier onset and phenoconvertion of Rapid-eye-movement sleep behavior disorder

    K. Senkevich, A. Pelletier, C. Sato, A. Keil, Z. Gan-Or, A. Lang, R. Postuma, E. Rogaeva (Montreal, Canada)

    Objective: In the current study, we aim to evaluate whether Rapid-eye-movement sleep behavior disorder (RBD) age-at-onset and age-at-phenoconversion are associated with DNA methylation-age acceleration (DNAm-AA).…
  • 2023 International Congress

    Keyboard tapping performance in people with subjective REM sleep behaviour disorder

    H. Chohan, C. Simonet, M. Periñán, L. Pérez-Carbonell, G. Leschziner, A. Gill, J. Bestwick, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: The aim of this study was to compare the BRAIN test performance of people with subjective RBD (sRBD, defined by RBD screening questionnaire score >53)…
  • 2023 International Congress

    Cortical thickness and global atrophy progression in Parkinson’s disease with probable RBD

    J. Oltra, A. Campabadal, C. Uribe, J. Pardo, I. Roura, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

    Objective: To explore 3-year cortical thickness (CTh) and global atrophy progression in treated Parkinson’s disease (PD) with probable REM sleep behavior disorder (RBD). Background: Parkinson’s…
  • 2023 International Congress

    Recruiting for Parkinson’s disease risk: Successful engagement tactics to screen for hyposmia in undiagnosed individuals

    M. Kuhl, R. Dobkin, L. Lemon, C. Destro, C. Kelliher, T. Rosenbaum, N. Islam, K. Lynch, L. Heathers, M. Totten, E. Bryan, C. Stanley, C. Hobbick, B. Mcmahon, K. Fabrizio, K. Marek (New York, USA)

    Objective: Describe recruitment tactics for engaging community in Parkinson’s disease remote risk screening Background: Early clinical markers of PD are critical to identifying biomarker signatures…
  • 2023 International Congress

    Uncovering the mechanisms of genotype by environment interaction in an idiopathic Parkinson’s disease model in Drosophila

    P. Olguin, G. Olivares, N. Candia, F. Núñez-Villegas, A. Klein (Santiago, Chile)

    Objective: To identify the genetic basis and the molecular mechanisms that underlie the susceptibility of developing motor defects in response to exposure to pesticides in…
  • 2023 International Congress

    Clinical analysis of Levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease. A single-center retrospective cohort study.

    D. Rivero Rodriguez, G. Tabar Comellas, MI. Morales Casado, AM. Diezma Martin, D. Garcia Melendez, M. Ennazeh Elkhaili, N. López Ariztegui (Toledo, Spain)

    Objective: To evaluate clinical impact of treatment (LCIG) infusion in patients with advanced PD. Background: Levodopa/carbidopa intestinal gel (LCIG) infusion has demonstrated more stable plasma…
  • 2023 International Congress

    Harmonizing genetic testing for early-onset Parkinson’s disease: results of the PARKNET multicentric study

    M. Percetti, E. Monfrini, I. Palmieri, A. Albanese, M. Avenali, A. Bartoletti-Stella, F. Blandini, G. Brescia, G. Calandra-Buonaura, R. Campopiano, S. Capellari, I. Colangelo, G. Comi, G. Cuconato, R. Ferese, C. Galandra, S. Gambardella, B. Garavaglia, A. Gaudio, E. Giardina, F. Invernizzi, P. Mandich, R. Mineri, C. Panteghini, C. Reale, L. Trevisan, S. Zampatti, P. Cortelli, E. Valente, A. Di Fonzo (Milano, Italy)

    Objective: To harmonize the interpretation of genetic testing in Parkinson's disease (PD) across the PARKNET network, as well as to provide a comprehensive assessment of…
  • 2023 International Congress

    10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

    P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

    Objective: To present data on 10 year longitudinal clinical and biological characteristics of sporadic Parkinson Disease (sPD) participants in the Parkinson’s Progression Markers Initiative (PPMI)…
  • 2023 International Congress

    Modulation of a subthalamic nucleus related network associated with motor response following Deep Brain Stimulation

    P. Unadkat, S. Peng, Y. Ma, V. Dhawan, C. Tang, A. Vo, S. Caminiti, D. Perani, D. Eidelberg (Manhasset, USA)

    Objective: To identify a network associated with the therapeutic effects of STN DBS Background: The network topography associated with the therapeutic effects of STN DBS…
  • 2023 International Congress

    Telemedicine challenges in the management of patients with Parkinson’s disease in Central Asia.

    A. Iliazova, E. Zhunusova, C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study is to identify challenges for telemedicine in treatment among patients with parkinsonism in Kyrgyzstan and Kazakhstan. Background: The covid-19…
  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley